161 related articles for article (PubMed ID: 15642351)
1. Baicalein 5,6,7-trimethyl ether, a flavonoid derivative, stimulates fatty acid beta-oxidation in skin fibroblasts of X-linked adrenoleukodystrophy.
Morita M; Takahashi I; Kanai M; Okafuji F; Iwashima M; Hayashi T; Watanabe S; Hamazaki T; Shimozawa N; Suzuki Y; Furuya H; Yamada T; Imanaka T
FEBS Lett; 2005 Jan; 579(2):409-14. PubMed ID: 15642351
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of pharmacological induction of fatty acid beta-oxidation in X-linked adrenoleukodystrophy.
McGuinness MC; Zhang HP; Smith KD
Mol Genet Metab; 2001; 74(1-2):256-63. PubMed ID: 11592822
[TBL] [Abstract][Full Text] [Related]
3. Elongation of very long-chain fatty acids is enhanced in X-linked adrenoleukodystrophy.
Kemp S; Valianpour F; Denis S; Ofman R; Sanders RJ; Mooyer P; Barth PG; Wanders RJ
Mol Genet Metab; 2005 Feb; 84(2):144-51. PubMed ID: 15670720
[TBL] [Abstract][Full Text] [Related]
4. [Adrenoleukodystrophy: molecular pathogenesis and development of therapeutic agents].
Morita M
Yakugaku Zasshi; 2007 Jul; 127(7):1059-64. PubMed ID: 17603264
[TBL] [Abstract][Full Text] [Related]
5. Effects of the testosterone metabolite dihydrotestosterone and 5 alpha-androstan-3 alpha,17 beta-diol on very long chain fatty acid metabolism in X-adrenoleukodystrophic fibroblasts.
Petroni A; Blasevich M; Uziel G
Life Sci; 2003 Aug; 73(12):1567-75. PubMed ID: 12865096
[TBL] [Abstract][Full Text] [Related]
6. Metabolism of saturated and polyunsaturated very-long-chain fatty acids in fibroblasts from patients with defects in peroxisomal beta-oxidation.
Street JM; Singh H; Poulos A
Biochem J; 1990 Aug; 269(3):671-7. PubMed ID: 2117919
[TBL] [Abstract][Full Text] [Related]
7. Adrenoleukodystrophy: impaired oxidation of very long chain fatty acids in white blood cells, cultured skin fibroblasts, and amniocytes.
Singh I; Moser AE; Moser HW; Kishimoto Y
Pediatr Res; 1984 Mar; 18(3):286-90. PubMed ID: 6728562
[TBL] [Abstract][Full Text] [Related]
8. Lovastatin and sodium phenylacetate normalize the levels of very long chain fatty acids in skin fibroblasts of X- adrenoleukodystrophy.
Singh I; Pahan K; Khan M
FEBS Lett; 1998 Apr; 426(3):342-6. PubMed ID: 9600263
[TBL] [Abstract][Full Text] [Related]
9. Baicalein 5,6,7-trimethyl ether activates peroxisomal but not mitochondrial fatty acid beta-oxidation.
Morita M; Kanai M; Mizuno S; Iwashima M; Hayashi T; Shimozawa N; Suzuki Y; Imanaka T
J Inherit Metab Dis; 2008 Jun; 31(3):442-9. PubMed ID: 18470630
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic effects of normal cells on ABCD1 deficient cells in vitro and hematopoietic cell transplantation in the X-ALD mouse model.
Yamada T; Ohyagi Y; Shinnoh N; Kikuchi H; Osoegawa M; Ochi H; Kira J; Furuya H
J Neurol Sci; 2004 Mar; 218(1-2):91-7. PubMed ID: 14759639
[TBL] [Abstract][Full Text] [Related]
11. Carrier identification of X-linked adrenoleukodystrophy by measurement of very long chain fatty acids and lignoceric acid oxidation.
Inoue K; Suzuki Y; Yajima S; Shimozawa N; Tomatsu S; Orii T; Kondo N
Clin Genet; 1996 Nov; 50(5):348-52. PubMed ID: 9007322
[TBL] [Abstract][Full Text] [Related]
12. Early oxidative damage underlying neurodegeneration in X-adrenoleukodystrophy.
Fourcade S; López-Erauskin J; Galino J; Duval C; Naudi A; Jove M; Kemp S; Villarroya F; Ferrer I; Pamplona R; Portero-Otin M; Pujol A
Hum Mol Genet; 2008 Jun; 17(12):1762-73. PubMed ID: 18344354
[TBL] [Abstract][Full Text] [Related]
13. The effect of Lorenzo's oil on oxidative stress in X-linked adrenoleukodystrophy.
Deon M; Wajner M; Sirtori LR; Fitarelli D; Coelho DM; Sitta A; Barschak AG; Ferreira GC; Haeser A; Giugliani R; Vargas CR
J Neurol Sci; 2006 Sep; 247(2):157-64. PubMed ID: 16750542
[TBL] [Abstract][Full Text] [Related]
14. Cholesterol-deprivation increases mono-unsaturated very long-chain fatty acids in skin fibroblasts from patients with X-linked adrenoleukodystrophy.
Engelen M; Ofman R; Mooijer PA; Poll-The BT; Wanders RJ; Kemp S
Biochim Biophys Acta; 2008 Mar; 1781(3):105-11. PubMed ID: 18206987
[TBL] [Abstract][Full Text] [Related]
15. Therapy for X-adrenoleukodystrophy: normalization of very long chain fatty acids and inhibition of induction of cytokines by cAMP.
Pahan K; Khan M; Singh I
J Lipid Res; 1998 May; 39(5):1091-100. PubMed ID: 9610777
[TBL] [Abstract][Full Text] [Related]
16. Determination of 30 X-linked adrenoleukodystrophy mutations, including 15 not previously described.
Lachtermacher MB; Seuánez HN; Moser AB; Moser HW; Smith KD
Hum Mutat; 2000; 15(4):348-53. PubMed ID: 10737980
[TBL] [Abstract][Full Text] [Related]
17. X-linked adrenoleukodystrophy: role of very long-chain acyl-CoA synthetases.
Jia Z; Pei Z; Li Y; Wei L; Smith KD; Watkins PA
Mol Genet Metab; 2004; 83(1-2):117-27. PubMed ID: 15464426
[TBL] [Abstract][Full Text] [Related]
18. Adrenoleukodystrophy: elevated C26 fatty acid in cultured skin fibroblasts.
Moser HW; Moser AB; Kawamura N; Murphy J; Suzuki K; Schaumburg H; Kishimoto Y
Ann Neurol; 1980 Jun; 7(6):542-9. PubMed ID: 7436359
[TBL] [Abstract][Full Text] [Related]
19. [From gene to disease; X-linked adrenoleukodystrophy].
Engelen M; Kemp S; van Geel BM
Ned Tijdschr Geneeskd; 2008 Apr; 152(14):804-8. PubMed ID: 18491823
[TBL] [Abstract][Full Text] [Related]
20. Protease inhibitors suppress the degradation of mutant adrenoleukodystrophy proteins but do not correct impairment of very long chain fatty acid metabolism in adrenoleukodystrophy fibroblasts.
Yamada T; Shinnoh N; Kobayashi T
Neurochem Res; 1997 Mar; 22(3):233-7. PubMed ID: 9051655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
